(815) 929-9292
(217) 328-2828
(217) 443-4343
(217) 516-3451
Hablamos Español

Roundup Litigation Comes to Multi-Billion Dollar Agreement

Bayer recently announced agreements designed to resolve major Monsanto litigation, including U.S. Roundup product liability litigation, dicamba drift litigation, and PCB water litigation. In addition to these agreements, the company has put in place a mechanism to efficiently resolve potential future claims. Bayer will be making a payment of $8.8 billion to $9.6 billion to resolve Roundup litigation, which the company regards as a reasonable resolution to this unique litigation.

The Roundup litigation includes a multi-step resolution with several elements. The agreements are designed to resolve the vast majority of current litigation, as well as plaintiffs with filed cases and parties with retained counsel but unfiled claims in court. Those who choose to participate in the settlement will be required to dismiss their case altogether or agree to not file it.

Under the agreements, future Roundup litigation cases will be governed by a class agreement that will be subject to court approval, including the establishment of an independent Class Science Panel. The panel will exert their efforts in determining whether Roundup can cause non-Hodgkin’s lymphoma (NHL) and at what minimum exposure levels, which is expected to take several years. Bayer, a science-based company, announced that consumers, including farmers and other professional users that depend on glyphosate-based products for their livelihoods, will not see a change in the availability of Roundup products.

Cash payments under the agreements are expected to start in 2020. If you or a loved one suffered from non-Hodgkin’s lymphoma after using Roundup products, you may be entitled to receive financial compensation under these agreements. To assist you in litigation efforts, contact one of our qualified attorneys from Spiros Law, P.C. at (815) 929-9292. An attorney will be able to consult with you over the phone and answer any questions you may have.